Rate My Professor Subree Subramanian

Subramanian's research program elucidates molecular mechanisms of immune evasion in cancers, particularly colorectal cancer and osteosarcoma, focusing on tumor-derived extracellular vesicles, gut microbiome interactions, and atypical chemokine receptor 4 (ACKR4) in anti-tumor immunity. His lab has identified how cancer cells and the microbiome suppress immune responses, including T-cell costimulation via exosomes, with implications for immunotherapy. He has authored over 120 peer-reviewed articles, including key publications such as 'Tumor-derived extracellular vesicles in the colorectal cancer immune environment and immunotherapy' (Pharmacology & Therapeutics, 2023), 'Cancer Immunology and Immunotherapies: Mechanisms that affect antitumor immune response and treatment resistance' (Cancers, 2021), and 'Tumor-secreted extracellular vesicles regulate T-cell costimulation and can be manipulated to induce tumor-specific T-cell responses' (Gastroenterology, 2021). His work has garnered an h-index of 54, over 10,500 citations, and an i10-index of 124. Notable awards include the American Cancer Society Research Scholar Award (2013), University of Minnesota Frontiers in Biomedical Research Scholar Award (2013), and Masonic Scholar from the Masonic Cancer Center (2010). He serves as Section Editor-in-Chief for Vaccines and Associate Section Editor-in-Chief for Cancers, and holds memberships in the American Association for Cancer Research, American Association for Immunologists, Society for Immunotherapy of Cancer, and International Society for Extracellular Vesicles.